{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T10:46:09Z","timestamp":1792320369023,"version":"4.4.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100014759","name":"Medical Scientific Research Foundation of Zhejiang Province, China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014759","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Anesthesia"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.jclinane.2025.111871","type":"journal-article","created":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T12:06:35Z","timestamp":1747310795000},"page":"111871","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Perioperative management of patients on GLP-1 receptor agonists: Risks, recommendations, and future directions\u2014A narrative review"],"prefix":"10.1016","volume":"104","author":[{"given":"Xiao-Yu","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiu-Ye","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui-Chun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Ping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jclinane.2025.111871_bb0005","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.2040-1124.2010.00022.x","article-title":"GIP and GLP-1, the two incretin hormones: similarities and differences","volume":"1","author":"Seino","year":"2010","journal-title":"J Diab Investig"},{"key":"10.1016\/j.jclinane.2025.111871_bb0010","doi-asserted-by":"crossref","first-page":"4217","DOI":"10.1172\/JCI97233","article-title":"Discovery, characterization, and clinical development of the glucagon-like peptides","volume":"127","author":"Drucker","year":"2017","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jclinane.2025.111871_bb0015","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/nrendo.2012.140","article-title":"GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus","volume":"8","author":"Meier","year":"2012","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.jclinane.2025.111871_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2020.101102","article-title":"GLP-1 receptor agonists in the treatment of type 2 diabetes - state-of-the-art","volume":"46","author":"Nauck","year":"2021","journal-title":"Mol Metab"},{"key":"10.1016\/j.jclinane.2025.111871_bb0025","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1080\/14728214.2021.1947240","article-title":"Emerging glucagon-like peptide 1 receptor agonists for the treatment of obesity","volume":"26","author":"Jepsen","year":"2021","journal-title":"Expert Opin Emerg Drugs"},{"key":"10.1016\/j.jclinane.2025.111871_bb0030","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1007\/s12630-023-02440-3","article-title":"Semaglutide, delayed gastric emptying, and intraoperative pulmonary aspiration: a case report","volume":"70","author":"Klein","year":"2023","journal-title":"Can J Anesth"},{"key":"10.1016\/j.jclinane.2025.111871_bb0035","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.42153","article-title":"Anesthesia considerations for a patient on Semaglutide and delayed gastric emptying","author":"Fujino","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.jclinane.2025.111871_bb0040","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1007\/s12630-023-02521-3","article-title":"Regurgitation under anesthesia in a fasted patient prescribed semaglutide for weight loss: a case report","volume":"70","author":"Gulak","year":"2023","journal-title":"J Can Anesth"},{"key":"10.1016\/j.jclinane.2025.111871_bb0045","doi-asserted-by":"crossref","first-page":"G424","DOI":"10.1152\/ajpgi.2002.282.3.G424","article-title":"Effect of GLP-1 on gastric volume, emptying, maximum volume ingested, and postprandial symptoms in humans","volume":"282","author":"Delgado-Aros","year":"2002","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jclinane.2025.111871_bb0050","doi-asserted-by":"crossref","first-page":"785","DOI":"10.2337\/db13-0893","article-title":"Comparative effects of prolonged and intermittent stimulation of the glucagon-like peptide 1 receptor on gastric emptying and glycemia","volume":"63","author":"Umapathysivam","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.jclinane.2025.111871_bb0055","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/dom.13956","article-title":"Exenatide once weekly slows gastric emptying of solids and liquids in healthy, overweight people at steady-state concentrations","volume":"22","author":"Jones","year":"2020","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.jclinane.2025.111871_bb0060","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.regpep.2008.07.003","article-title":"Effect of exenatide on gastric emptying and relationship to postprandial glycemia in type 2 diabetes","volume":"151","author":"Linnebjerg","year":"2008","journal-title":"Regul Pept"},{"key":"10.1016\/j.jclinane.2025.111871_bb0065","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s12325-010-0110-x","article-title":"The once-daily human glucagon-like peptide-1 (GLP-1) analog liraglutide improves postprandial glucose levels in type 2 diabetes patients","volume":"28","author":"Flint","year":"2011","journal-title":"Adv Ther"},{"key":"10.1016\/j.jclinane.2025.111871_bb0070","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/S0140-6736(08)61206-4","article-title":"Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study","volume":"372","author":"Drucker","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.jclinane.2025.111871_bb0075","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1002\/oby.23481","article-title":"Effects of liraglutide on gastrointestinal functions and weight in obesity: a randomized clinical and pharmacogenomic trial","volume":"30","author":"Maselli","year":"2022","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.jclinane.2025.111871_bb0080","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S2468-1253(17)30285-6","article-title":"Effects of liraglutide on weight, satiation, and gastric functions in obesity: a randomised, placebo-controlled pilot trial","volume":"2","author":"Halawi","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jclinane.2025.111871_bb0085","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1111\/dom.14944","article-title":"Semaglutide delays 4-hour gastric emptying in women with polycystic ovary syndrome and obesity","volume":"25","author":"Jensterle","year":"2023","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.jclinane.2025.111871_bb0090","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1038\/ijo.2013.162","article-title":"Effects of the once-daily GLP-1 analog liraglutide on gastric emptying, glycemic parameters, appetite and energy metabolism in obese, non-diabetic adults","volume":"38","author":"van Can","year":"2014","journal-title":"Int J Obes"},{"key":"10.1016\/j.jclinane.2025.111871_bb0095","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/osp4.486","article-title":"Energy intake as a short-term biomarker for weight loss in adults with obesity receiving liraglutide: a randomized trial","volume":"7","author":"Saxena","year":"2021","journal-title":"Obes Sci Pract"},{"key":"10.1016\/j.jclinane.2025.111871_bb0100","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.2337\/dc14-1984","article-title":"Contrasting effects of Lixisenatide and Liraglutide on postprandial glycemic control, gastric emptying, and safety parameters in patients with type 2 diabetes on optimized insulin glargine with or without metformin: a randomized, open-label trial","volume":"38","author":"Meier","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jclinane.2025.111871_bb0105","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/dom.13120","article-title":"Semaglutide improves postprandial glucose and lipid metabolism, and delays first-hour gastric emptying in subjects with obesity","volume":"20","author":"Hjerpsted","year":"2018","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.jclinane.2025.111871_bb0110","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1111\/dom.14373","article-title":"Oral semaglutide improves postprandial glucose and lipid metabolism, and delays gastric emptying, in subjects with type 2 diabetes","volume":"23","author":"Dahl","year":"2021","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.jclinane.2025.111871_bb0115","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/dom.14280","article-title":"The effect of semaglutide 2.4 mg once weekly on energy intake, appetite, control of eating, and gastric emptying in adults with obesity","volume":"23","author":"Friedrichsen","year":"2021","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.jclinane.2025.111871_bb0120","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1023\/A:1011935603893","article-title":"How useful is paracetamol absorption as a marker of gastric emptying? A systematic literature study","volume":"46","author":"Willems","year":"2001","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jclinane.2025.111871_bb0125","article-title":"Prevalence and variations in gastric emptying delay in response to GLP-1 receptor agonist liraglutide","author":"Camilleri","year":"2023","journal-title":"Obesity"},{"key":"10.1016\/j.jclinane.2025.111871_bb0130","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0016-5085(83)80232-7","article-title":"Regulation of the gastric emptying of glucose","volume":"85","author":"Brener","year":"1983","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jclinane.2025.111871_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2024.108793","article-title":"Effect of lixisenatide on liquid gastric emptying in type 2 diabetes - implications for the use of GLP-1 receptor agonists before procedures","volume":"38","author":"Kovoor","year":"2024","journal-title":"J Diabetes Complicat"},{"key":"10.1016\/j.jclinane.2025.111871_bb0140","article-title":"Particulate gastric contents in patients prescribed glucagon-like peptide 1 receptor agonists after appropriate perioperative fasting: a report of 2 cases","volume":"17","author":"Wilson","year":"2023","journal-title":"A&A Pract"},{"key":"10.1016\/j.jclinane.2025.111871_bb0145","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1007\/s12630-023-02549-5","article-title":"Influence of semaglutide use on the presence of residual gastric solids on gastric ultrasound: a prospective observational study in volunteers without obesity recently started on semaglutide","volume":"70","author":"Sherwin","year":"2023","journal-title":"Can J Anaesth"},{"key":"10.1016\/j.jclinane.2025.111871_bb0150","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/jdi.14005","article-title":"Association of glucagon-like peptide-1 receptor agonist treatment with gastric residue in an esophagogastroduodenoscopy","volume":"14","author":"Kobori","year":"2023","journal-title":"J Diab Investig"},{"key":"10.1016\/j.jclinane.2025.111871_bb0155","article-title":"Association of glucagon-like peptide receptor 1 agonist therapy with the presence of gastric contents in fasting patients undergoing endoscopy under anesthesia care: a historical cohort study","author":"Wu","year":"2024","journal-title":"Can J Anaesth"},{"key":"10.1016\/j.jclinane.2025.111871_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.jclinane.2023.111091","article-title":"Relationship between perioperative semaglutide use and residual gastric content: a retrospective analysis of patients undergoing elective upper endoscopy","volume":"87","author":"Silveira","year":"2023","journal-title":"J Clin Anesth"},{"key":"10.1016\/j.jclinane.2025.111871_bb0165","article-title":"Clinical outcomes and safety of upper endoscopy while on glucagon-like Peptide-1 receptor agonists","author":"Firkins","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jclinane.2025.111871_bb0170","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.gie.2024.04.2900","article-title":"Effects of glucagon-like peptide-1 receptor agonists on upper endoscopy in diabetic and nondiabetic patients","volume":"100","author":"Nadeem","year":"2024","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.jclinane.2025.111871_bb0175","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1177\/10600280211055804","article-title":"Impact of glucagon-like Peptide-1 receptor agonists (GLP-1RA) on food content during esophagogastroduodenoscopy (EGD)","volume":"56","author":"Stark","year":"2022","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jclinane.2025.111871_bb0180","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.gie.2024.05.012","article-title":"Effects of glucagon-like peptide-1 receptor agonists on gastric mucosal visibility and retained gastric contents during EGD","volume":"100","author":"Chapman","year":"2024","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.jclinane.2025.111871_bb0185","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.14309\/ajg.0000000000002777","article-title":"Glucagon-like Peptide-1 receptor agonists increase solid gastric residue rates on upper endoscopy especially in patients with complicated diabetes: a case-control study","volume":"119","author":"Garza","year":"2024","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jclinane.2025.111871_bb0190","doi-asserted-by":"crossref","DOI":"10.14309\/ajg.0000000000002820","article-title":"Quantified metrics of gastric emptying delay by glucagon-like Peptide-1 agonists: a systematic review and Meta-analysis with insights for Periprocedural management","author":"Hiramoto","year":"2024","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jclinane.2025.111871_bb0195","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1001\/jamasurg.2024.0111","article-title":"Glucagon-like Peptide-1 receptor agonist use and residual gastric content before anesthesia","volume":"159","author":"Sen","year":"2024","journal-title":"JAMA Surg"},{"key":"10.1016\/j.jclinane.2025.111871_bb0200","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1111\/anae.16454","article-title":"Relationship between residual gastric content and peri-operative semaglutide use assessed by gastric ultrasound: a prospective observational study","volume":"79","author":"Nersessian","year":"2024","journal-title":"Anaesthesia"},{"key":"10.1016\/j.jclinane.2025.111871_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.jclinane.2024.111668","article-title":"Effect of various perioperative semaglutide interruption intervals on residual gastric content assessed by esophagogastroduodenoscopy: a retrospective single center observational study","volume":"99","author":"Santos","year":"2024","journal-title":"J Clin Anesth"},{"key":"10.1016\/j.jclinane.2025.111871_bb0210","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1007\/s11695-024-07278-2","article-title":"Safe continuation of glucagon-like peptide 1 receptor agonists at endoscopy: a case series of 57 adults undergoing endoscopic sleeve gastroplasty","volume":"34","author":"Maselli","year":"2024","journal-title":"Obes Surg"},{"issue":"25","key":"10.1016\/j.jclinane.2025.111871_bb0215","first-page":"00009","article-title":"Endoscopy and anesthesia outcomes associated with glucagon-like Peptide-1 receptor agonist use in patients undergoing outpatient upper endoscopy","volume":"S0016-5107","author":"Panchal","year":"2025","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.jclinane.2025.111871_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.jclinane.2025.111776","article-title":"Perioperative glucagon-like peptide-1 receptor agonist use and retained gastric contents: a retrospective analysis of patients undergoing elective upper endoscopy","volume":"102","author":"Quinn","year":"2025","journal-title":"J Clin Anesth"},{"key":"10.1016\/j.jclinane.2025.111871_bb0225","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/ALN.0000000000004776","article-title":"ASA consensus-based guidance on preoperative management of patients on glucagon-like Peptide-1 receptor agonists","volume":"140","author":"Ushakumari","year":"2024","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jclinane.2025.111871_bb0230","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.cgh.2023.11.002","article-title":"AGA rapid clinical practice update on the management of patients taking GLP-1 receptor agonists prior to endoscopy: communication","volume":"22","author":"Hashash","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"24","key":"10.1016\/j.jclinane.2025.111871_bb0235","first-page":"00910","article-title":"Multisociety clinical practice guidance for the safe use of glucagon-like Peptide-1 receptor agonists in the perioperative period","volume":"S1542-3565","author":"Kindel","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jclinane.2025.111871_bb0240","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.gie.2024.10.057","article-title":"American Society for Gastrointestinal Endoscopy position statement on periendoscopic management of patients on glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors","volume":"101","author":"Sharaiha","year":"2025","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.jclinane.2025.111871_bb0245","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/anae.16541","volume":"80","author":"El-Boghdadly","year":"2025","journal-title":"Anaesthesia"},{"key":"10.1016\/j.jclinane.2025.111871_bb0250","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.cgh.2023.11.024","article-title":"Low incidence of pulmonary aspiration during upper endoscopy in patients prescribed a glucagon-like peptide 1 receptor agonist","volume":"22","author":"Anazco","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jclinane.2025.111871_bb0255","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2024-080340","article-title":"Glucagon-like peptide-1 receptor agonists before upper gastrointestinal endoscopy and risk of pulmonary aspiration or discontinuation of procedure: cohort study","volume":"387","author":"Alkabbani","year":"2024","journal-title":"BMJ"},{"key":"10.1016\/j.jclinane.2025.111871_bb0260","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1053\/j.gastro.2024.03.015","article-title":"Increased risk of aspiration pneumonia associated with endoscopic procedures among patients with glucagon-like peptide 1 receptor agonist use","volume":"167","author":"Yeo","year":"2024","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jclinane.2025.111871_bb0265","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1111\/dom.14110","article-title":"The novel dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide transiently delays gastric emptying similarly to selective long-acting GLP-1 receptor agonists","volume":"22","author":"Urva","year":"2020","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.jclinane.2025.111871_bb0270","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1111\/dom.15167","article-title":"The novel GIP, GLP-1 and glucagon receptor agonist retatrutide delays gastric emptying","volume":"25","author":"Urva","year":"2023","journal-title":"Diabetes Obes Metab"}],"container-title":["Journal of Clinical Anesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095281802500131X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095281802500131X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T10:14:04Z","timestamp":1762337644000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S095281802500131X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":54,"alternative-id":["S095281802500131X"],"URL":"https:\/\/doi.org\/10.1016\/j.jclinane.2025.111871","relation":{},"ISSN":["0952-8180"],"issn-type":[{"value":"0952-8180","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Perioperative management of patients on GLP-1 receptor agonists: Risks, recommendations, and future directions\u2014A narrative review","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Anesthesia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jclinane.2025.111871","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111871"}}